Document Page: First | Prev | Next | All | Image | This Release | Search
File: 011696_118_9_001.txt
Purpose. Tc) provide Information on the medical aspects of
itnthrax.
2. Facts.
a. Anthrax is caused by a spore forming bacteria which normally
affects @als primarily cattle. Under natural conditions.
man becomes Infected by contact with Infected animals.
Potential sites of disease occur In the skin, gastrointestinal
system and the has. The skin and Intestinal forms are more
common and easily treated.
b. Used as a biological weapon. anthrax results In pulmonary
disease, a rare form which is transmitted via Inhalation of
the spores. The means of delivery is aerosolization via
spraying or munition. once inhaled the onset of symptoms
varies from I - 5 days and Includes fever, weakness and a non-
productive cough. This Is followed by a recovery phase of 2 -
4 days. Subsequently, severe respiratory problems develop
leading to death In most cases. The shires are very
persistent and @ remain In the soil indefinitely despite
high temperatures.
c. The protective mask provides complete protection against the.-
inhalation of anthrax spores. A vaccine is available in
limited quantities but Is not currently scheduled for
administration to 24th ID (M) soldiers. Prophylaxis
(pre-treatment) with antibiotic ciprofloxacin is effective and
thus It will be Issued to all 24th ID soldiers through medical
cbanhels. The unit of issue is 10 tablets per soldier (5 day
supply, 2 tablets per day). Based upon the threat level, each
e
antibiotic doxycycline (100 mg twice a day) is an alternative
In patients allergic to ciprafloxacin.
d. Recognition of the employment of biological weapons Is
difficult. Currently, there are no mechanical rapid detection
systems. The use of biological weapons should be suspected
when any of the following are observed: munition producing
cloud or mlst, large numbers of deceased livestock, and an
unusual Incidence of flu - like symptoms or pneumonia In
personnel.
e. Upon high probability or confirmation of exposure to a
biological weapon agent Initiation of use of ciprofloxacin
will be determined by command. The dosing schedule will be I
tablet twice a day. Furthermore, if anthrax exposure Is
confirmed, clprofloxacin will be continued for 30 days as I
tablet twice a day. In addition, exposed unvaccinated
personnel will begin and complete the 2 shot anthrax vaccine
series during the 30 day course of antibiotics. Sufficient
quantities of ciprofloxacin for prophylaxis are available In
the Division. Quantities of vaccine and ciprofloxacin for
post - exposure treatment are being stockpiled In theater.
J. BenJamin HALL/Divislon Surgeon
9-7662-144
Box ID = BX000000
Unit = 101ID
Parent Organization = XVIII CORPS
Folder Title = ANTHRAX
Subject = ANTHRAX
Document Number = 118
Image file name = 00000298.tif
Document Page: First | Prev | Next | All | Image | This Release | Search